Connecting to LinkedIn...

W1siziisijiwmtuvmdqvmtuvmdgvntqvmzgvnzi1l01ptlrbu0hfqkxpr19vtljftkrfukvex0lnqudfx3jlc2l6zwrfyw5kx3jlbmrlcmvklmpwzyjdlfsiccisinrodw1iiiwimtkymhgxmjuwiyjdxq

Blog

Discoverx Announces Nature Biotechnology Publication Of Epa Toxcast Data Validating Biomap Systems’ Ability To Predict Drug, Chemical Toxicities

18/04/2014 by

W1siziisijiwmtqvmduvmtkvmtyvmdivmzgvnzc4l0rsef9sb2dvx2hyymlnlmpwzyjdlfsiccisinrodw1iiiwinjawedqwmfx1mdazzsjdxq

Newly published research demonstrates the ability of BioMAP Systems,  a unique set of primary human cell and co-culture assays that model human disease and pathway biology, to identify important safety aspects of drugs and chemicals more efficiently and accurately than can be achieved by animal testing. Data from BioMAP Systems analysis of 776 environmental chemicals, including reference pharmaceuticals and failed drugs, on their ability to disrupt physiologically important human biological pathways were published online this week in Nature Biotechnology. The results show that this in vitro approach can reproducibly identify potential toxicities and off-target drug effects, as well as pinpoint cellular mechanisms and specifically affected biomarker endpoints underlying specific types of adverse reactions in humans. DiscoveRx Corporation’s BioSeek division conducted the analysis in collaboration with scientists from the U.S. Environmental Protection Agency as part of the EPA ToxCast Program.

Assessing the safety aspects of drugs, consumer products and environmental chemicals has been historically undertaken through animal testing. However, the vast number of chemicals needing such toxicological assessment  and the fact that results in animals often do not translate well to results in humans require the development of alternative, faster, more accurate and humane testing approaches.

This article has been extracted from http://www.prnewswire.com, please click on this link to read the article in full http://www.prnewswire.com/news-releases/discoverx-announces-nature-biotechnology-publication-of-epa-toxcast-data-validating-biomap-systems-ability-to-predict-drug-chemical-toxicities-259783971.html

Montash is a multi-award winning, global IT recruitment firm. Specialising in permanent and contract positions across mid-senior appointments which cover a wide range of industry sectors and IT functions, including:

ERP, BI & Data, Information Security, IT Architecture & Strategy, Scientific Technologies, Demand IT and Business Engagement, Digital and E-commerce, Infrastructure and Service Delivery, Project and Programme Delivery.

With offices based in London, Montash has completed assignments in over 30 countries and has appointed technical professionals from board level to senior and mid-management in permanent and contract roles.

comments powered by Disqus

Social Stream

Latest News

W1siziisijiwmtyvmtivmduvmtqvmdavmjivmzm1l0jpzybeyxrhlmpwzyjdlfsiccisinrodw1iiiwimzgwedewmcmixv0

Big data analytics – governed data discovery ...

2016-12-05 13:00:00 +0000

Big data analytics has matured as a business process during 2016 with most enterprises now recognising the critical importance of actively mining big data for insights. These insights will inform decision-making and ensure they remain competitive in an increasingly complex landscape that is constantly in flux. One prediction that will certainly come to fruition in the coming years is “more data”. The world’s storage systems are set to hold more than 17....

W1siziisijiwmtyvmtivmdivmtavmdcvntcvotkwl2j1c2luzxnzigludgvsbglnzw5jzs5qcgcixsxbinailcj0ahvtyiisijm4mhgxmdajil1d

Annual growth rate for BI market set at 8.4%

2016-12-02 10:00:00 +0000

A new report has suggested that the compound average growth rate (CAGR) for the business intelligence (BI) market between 2016 and 2021 is likely to be around 8.4 per cent. The latest publication, named Global Business Intelligence Market by Mobile BI, Cloud BI, and Other Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015-2021, said that 2015 saw the global BI sector valued at $16.33 billion. By 2021, this is expected t...